WASHINGTON — The Federal Motor Carrier Safety Administration is requesting public comments on a proposed form relating to insulin-dependent diabetes.
The agency is anticipating a final rule bringing to an end the ban against the operation of commercial motor vehicles in interstate commerce by insulin-dependent diabetic drivers.
The agency is required to submit an Information Collection Request to the White House Office of Management and Budget for its review and approval when considering a change to information collection.
The agency previously published a proposed rule in 2015 on insulin-dependent diabetes and received public comments and recommendations from its Medical Review Board.
Based on the board’s analysis and recommendations, FMCSA is considering replacing the previously proposed written notification from the treating clinician with a form titled “Insulin-Treated Diabetes Mellitus Assessment Form,” to be completed by the clinician and provided to a certified medical examiner.
The form could be required for CMV drivers treated with insulin for diabetes who wish to drive in interstate commerce.
FMCSA is accepting public comments on the proposed revision and the form. Comments can be submitted on or before September 25, 2017, at https://www.regulations.gov, referencing Federal Docket Management System Docket Number FMCSA-2005-23151.
